Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07168941

Evaluation and Refinement of KF-STRIDE Into the Interview!

Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Although KF-STRIDE 2.0 was designed to support youth on the spectrum, its current design may not be appropriate for adults. Thus, the current proposal will support development activities to significantly adapt KF-STRIDE 2.0 to meet the specific needs of adults with autism. As part of development, we will partner with the autism community, using mixed methodology to ensure our modifications are performed with community-engaged methods. We will invite adults with autism, family members, employers, and vocational counselors to provide feedback to guide the modifications to KF-STRIDE. We will then test the acceptability, feasibility, fidelity, and initial efficacy of KF-STRIDE 3.0 among adults on the spectrum. Obtaining employment is essential to individuals on the spectrum as it can lead to improved community integration, increased social networking, and a means to contribute to society as productive citizens. Overall, we propose to adapt a treatment that has strong potential to help adults with autism improve their job interview skills that will lead to increased employment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • You live in the United States of America
  • You speak English Fluently and at a 4th grade reading level

Exclusion criteria

  • You have a history of significant psychiatric illness (like bipolar disorder, schizophrenia, or psychosis)
  • You have a history of substance abuse

Treatment and study plan

KF-STRIDE

Behavioral

KF Stride works to improve identification (awareness) of personal character strengths and 2) express them in a socially appropriate way during a job interview

Primary outcomes

  1. 20-minute long video-recorded Mock Job Interview, Autism Mock Interview Rating-Scale(A-MIRS)

    Time frame: Baseline, Immediate Post-Test between weeks 7 and 8

    Participants will choose 1 of 7 possible employment positions (i.e., security, childcare, culinary arts). Digital recordings will be scored by blinded raters with human resources expertise and trained to a reliable standard. Briefly, raters will rate videos using the Autism Mock Interview Rating-Scale (A-MIRS). The A-MIRS rate will rate the participant's 'likeliness to be hired' as a global rating of overall interview skill (scaled from 1= "unlikely" to 5= "very likely"). Then, raters will rate 11 interview skills (using a Likert-type scale): 1) confidence; 2) being positive; 3) professionalism; 4) showing interest; 5) honesty; 6) being hardworking; 7) working with others; 8) sharing strengths and skills; 9) sharing past experiences; 10) sharing limitations; and 11) overall rapport. A total score will be evaluated.

  2. Work Readiness Scale

    Time frame: Baseline, Immediate Post-Test between weeks 7 and 8

    13 items about the perception of one's ability to work, with values ranging from 1 to 5, with higher scores meaning a better outcome.

  3. Employment Status

    Time frame: Baseline, Immediate Post-Test between weeks 7 and 8

    We will examine whether the person became employed or other changes to their employment status, (employment status, hours worked, wages earned, etc.) . Yes=1, No=0

Secondary outcomes

  1. World Health Organization Quality of Life abbreviated version (WHOQOL-BREF)

    Time frame: Baseline, Immediate Post-Test between weeks 7 and 8

    A self-report questionnaire which assesses 4 domains of quality of life (QOL): physical health, psychological health, social relationships, and environment

Study contacts

Contact information is provided by the study sponsor or research team.

Helen Genova

CONTACT

[email protected]

973-324-8390

Katarina Reduzzi

CONTACT

[email protected]

973-323-3750

Sponsors and collaborators

Lead sponsor

Kessler Foundation

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 11, 2025
Registry last updated
Sep 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.